Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (TODAY)

NCT03978494 PHASE1 WITHDRAWN

Study to compare pharmacokinetics of tacrolimus prolonged-release (PR) capsules and Advagraf® PR capsules in stable kidney transplant patients.

Details

Lead sponsor	Sandoz
Phase	PHASE1
Status	WITHDRAWN
Start date	Mon Sep 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun May 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Kidney Transplant

Interventions

• Advagraf®
• Generic tacrolimus

Countries

France, Germany